Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q43205975)
Watch
English
Protecting normal cells from the cytotoxicity of chemotherapy
scientific article published on 15 June 2012
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
3383581
retrieved
16 November 2017
title
Protecting normal cells from the cytotoxicity of chemotherapy
(English)
1 reference
stated in
Europe PubMed Central
PMCID
3383581
retrieved
16 November 2017
main subject
chemotherapy
1 reference
based on heuristic
inferred from title
author name string
Chit Fang Cheok
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
3383581
retrieved
16 November 2017
publication date
15 June 2012
1 reference
stated in
Europe PubMed Central
PMCID
3383581
retrieved
16 November 2017
number of pages
2
1 reference
based on heuristic
inferred from page(s)
published in
Cell Cycle
1 reference
stated in
Europe PubMed Central
PMCID
3383581
retrieved
16 November 2017
volume
11
1 reference
stated in
Europe PubMed Central
PMCID
3383581
retrieved
16 November 2017
issue
12
1 reference
stated in
Europe PubMed Central
PMCID
3383581
retrieved
16 November 2017
page(s)
2227-2228
1 reference
stated in
Europe PubMed Central
PMCID
3383581
retrieved
16 November 2017
cites work
An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383581
retrieved
25 May 2018
Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383581
retrieved
25 May 2018
A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383581
retrieved
25 May 2018
Nongenotoxic p53 activation protects cells against S-phase-specific chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383581
retrieved
25 May 2018
Exploiting cancer cell cycling for selective protection of normal cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383581
retrieved
25 May 2018
UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383581
retrieved
15 August 2018
Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22684296
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.4161/CC.20961
1 reference
stated in
Europe PubMed Central
PMCID
3383581
retrieved
16 November 2017
PMCID
3383581
1 reference
stated in
Europe PubMed Central
PMCID
3383581
retrieved
16 November 2017
PubMed ID
22684296
1 reference
stated in
Europe PubMed Central
PMCID
3383581
retrieved
16 November 2017
ResearchGate publication ID
225286941
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
